Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
29
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
25
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
24
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Capral
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Australian Infrastructure And Renewables Will Fuel Enduring Market Recovery
Key Takeaways Focus on green aluminium and infrastructure expansion strengthens sales stability and positions Capral for premium market share as sustainability trends accelerate. Investments in local manufacturing and value-added services are expected to improve operational efficiencies and drive higher margins.
View narrative
AU$16.05
FV
31.2% undervalued
intrinsic discount
8.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Oatly Group
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Global Plant-Based Trends Will Create Enduring Opportunity
Key Takeaways Accelerating supply chain and SG&A efficiencies, combined with brand reinvestment, are fueling faster-than-expected margin expansion and growth potential. Strong international channel growth, innovation, and sustainability positioning support outsized revenue gains and enduring leadership as global plant-based adoption rises.
View narrative
US$30.83
FV
42.3% undervalued
intrinsic discount
6.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Coveo Solutions
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Digital Transformation And AI Adoption Will Expand SaaS Ecosystems
Key Takeaways Generative AI adoption and deep enterprise partnerships are driving rapid revenue and margin acceleration, elevating Coveo's strategic indispensability within global digital transformation. Platform upselling, pricing optimization, and ecosystem leverage support durable profitability, sustained cash generation, and strong potential for significant capital returns.
View narrative
CA$14.98
FV
40.2% undervalued
intrinsic discount
14.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
3D Systems
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Additive Manufacturing And Personalized Healthcare Will Drive Secular Change
Key Takeaways Breakthroughs in bioprinting and dental technologies could enable leadership in organ and denture markets, supporting substantial, sustainable margin expansion. Unique value chain integration and material innovation position the company for diverse, recurring revenue streams as digital manufacturing and new verticals accelerate.
View narrative
US$4.00
FV
47.5% undervalued
intrinsic discount
-2.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Alpha Teknova
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Biopharma R&D And Cell Therapy Will Drive Custom Manufacturing
Key Takeaways Scalable infrastructure and advanced manufacturing position Teknova to outperform through new products, automation, and capitalizing on the trend toward outsourced biopharma reagent production. Expansion into personalized medicine and strategic acquisitions enhance growth prospects, while strong fundamentals reduce risk and increase potential for higher valuation and shareholder returns.
View narrative
US$12.00
FV
60.4% undervalued
intrinsic discount
14.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
CVRx
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Aging Population And Chronic Diseases Will Boost Heart Therapy Adoption
Key Takeaways Accelerated account expansion, effective talent strategies, and disease trends position CVRx for growth exceeding current forecasts and analyst expectations. Advancements in technology, digital integration, and global reach could significantly enhance both revenue quality and longer-term profitability.
View narrative
US$14.00
FV
44.3% undervalued
intrinsic discount
22.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Verano Holdings
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Legalization And Plant-Based Wellness Will Unlock Expansive Cannabis Markets
Key Takeaways Early state investments and operational efficiencies position Verano for significant outperformance if legalization and demand accelerate in key high-potential markets. Premium product innovation, omnichannel reach, and international readiness give Verano long-term advantages for sustained margin improvement and multi-market revenue growth.
View narrative
CA$6.01
FV
64.6% undervalued
intrinsic discount
1.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Service Properties Trust
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Asset Light Hospitality Will Harness Global Middle Class Demand
Key Takeaways Strategic focus on defensive net lease assets and renovations is expected to boost earnings growth, margins, and outperform industry benchmarks. Positioning in necessity-based properties and consolidation initiatives enables resilience, higher occupancy, and sustained long-term profitability.
View narrative
US$3.00
FV
6.7% undervalued
intrinsic discount
-8.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Quanterix
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Ultra-sensitive Proteomics Will Revolutionize Early Disease Detection Worldwide
Key Takeaways Simoa technology upgrades and operational realignment position the company for dominance in high-margin proteomics and spatial biology markets through expanded adoption and recurring revenue. Aggressive innovation, strategic acquisitions, and cost synergies are expected to accelerate earnings, margins, and new pharma partnerships while capturing a rapidly expanding diagnostics market.
View narrative
US$7.00
FV
31.0% undervalued
intrinsic discount
22.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies